HealthDay News — Large language model-based solutions can enhance clinical trial screening performance and reduce costs by automating the screening process, according to a study published online June ...

An online ordering portal was launched March 14, 2023, to expand distribution of HIVSTs directly to consumers. HealthDay News — Mailed HIV-self tests (HIVSTs) can increase testing among persons who ...

A majority (54%) of Americans said they are worried about how the government is dealing with the threat of climate change HealthDay News — Many Americans believe that their mental health is being ...

Lenacapavir was found to be superior to background HIV incidence and Truvada for HIV prevention. Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil ...

Researchers found that the risk for developing DLB was lower for men who were newly started on Tz/Dz/Az than those taking tamsulosin or 5ARI. Alexander Hart, MD, MPH, from the University of Michigan ...

Shortages are being caused by supply problems getting cotton and plastic. HealthDay News — Women are not imagining it as they view near-empty store shelves: Global supply chain issues have prompted a ...

Compared with placebo, a greater proportion of patients treated with Skyrizi achieved clinical remission in both the induction and maintenance trials. The Food and Drug Administration (FDA) has ...

This number was lower, but not significantly so, than the number seen in 2022. HealthDay News — In 2023, 7.6% of the US civilian noninstitutionalized population was uninsured, according to early ...

Credit: Merck. Capvaxive consists of pneumococcal polysaccharides from 21 serotypes, including 8 unique serotypes: 15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B. Capvaxive consists of pneumococcal ...

Vigafyde is a concentrated solution and requires a smaller volume than other vigabatrin products to obtain the same dosage. The Food and Drug Administration (FDA) has approved Vigafyde ™, a ...

Lumateperone met the primary endpoint achieving a statistically significant and clinically meaningful reduction in MADRS total score at week 6 vs placebo. Treatment with lumateperone, an atypical ...